(Q37589389)

21 August 2017

1 reference

title

The cytokine network in chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

21 August 2017

0 references

author name string

Peter J Barnes

series ordinal

1

1 reference

21 August 2017

28 August 2009

1 reference

American Journal of Respiratory Cell and Molecular Biology

21 August 2017

1 reference

21 August 2017

41

1 reference

21 August 2017

631-638

1 reference

21 August 2017

6

1 reference

The cytokine network in asthma and chronic obstructive pulmonary disease

21 August 2017

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Mediators of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Immunology of asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Dendritic cells in chronic obstructive pulmonary disease: new players in an old game

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Is alveolar destruction and emphysema in chronic obstructive pulmonary disease an immune disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Immunologic aspects of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

TNF-alpha antagonists and the prevention of hospitalisation for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Imbalances between interleukin-1 and tumor necrosis factor agonists and antagonists in stable COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

High levels of interleukin-6 in the exhaled breath condensate of patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Systemic manifestations and comorbidities of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Constitutive and inducible thymic stromal lymphopoietin expression in human airway smooth muscle cells: role in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Decreased expression of interleukin 13 in human lung emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

STAT4 activation in smokers and patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Th17 cells in airway diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

TH17 cells in the big picture of immunology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Essential autocrine regulation by IL-21 in the generation of inflammatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

IL-21: an executor of B cell fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Selective abrogation of Th1 response by STA-5326, a potent IL-12/IL-23 inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

The IL-12 family of cytokines in infection, inflammation and autoimmune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Association of interleukin (IL)-12 and IL-27 gene polymorphisms with chronic obstructive pulmonary disease in a Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Interleukin-18 production and pulmonary function in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Regulatory T cells, transforming growth factor-beta, and immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Cigarette smoke drives small airway remodeling by induction of growth factors in the airway wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Neutrophil elastase induces MUC5AC mucin production in human airway epithelial cells via a cascade involving protein kinase C, reactive oxygen species, and TNF-alpha-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Relationship of epidermal growth factor receptors to goblet cell production in human bronchi

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Inhibition of VEGF receptors causes lung cell apoptosis and emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Decreased T lymphocyte infiltration in bronchial biopsies of subjects with severe chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Exacerbations of Bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

CXCR2 antagonists for the treatment of pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Lymphoid follicle cells in chronic obstructive pulmonary disease overexpress the chemokine receptor CXCR3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Dynamics of pro-inflammatory and anti-inflammatory cytokine release during acute inflammation in chronic obstructive pulmonary disease: an ex vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Engineered antibody fragments and the rise of single domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Towards small-molecule CXCR3 ligands with clinical potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Role of HDAC2 in the pathophysiology of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Emerging pharmacotherapies for COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

PDE4 inhibitors: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Inhibitory effect of p38 mitogen-activated protein kinase inhibitors on cytokine release from human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

p38alpha-selective mitogen-activated protein kinase inhibitor SD-282 reduces inflammation in a subchronic model of tobacco smoke-induced airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Mepolizumab and exacerbations of refractory eosinophilic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Mepolizumab for prednisone-dependent asthma with sputum eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Increased activation of p38 MAPK in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

Elevated Levels of IL-18 in Plasma and Skeletal Muscle in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2009-0220TR

21 January 2018

Identifiers

DOI

10.1165/RCMB.2009-0220TR

1 reference

21 August 2017

1 reference

PubMed ID

19717810